Objective To investigate the association between use of combined oral contraceptives and
risk of venous thromboembolism, taking the type of progestogen into account. Design Two …

Controversy exists regarding whether oral contraceptives (OCs) containing desogestrel and
gestodene are associated with an increased risk of venous thromboembolism (VTE) versus …

Objectives To investigate the factors associated with idiopathic venous thromboembolism in
combined oral contraceptive users and to estimate the crude and age-specific incidence …

Overall, there was a modest, non-significant, positive association between exposure to
progestagens alone and venous thromboembolism (VTE). There was no effect with …

Since the introduction of oral contraceptives, their use has been associated with an
increased risk of both venous and arterial thrombosis. Pulmonary embolism, myocardial …

Recent epidemiologic studies reported that the risk of venous thromboembolism (VTE) was
higher with the use of the newer third generation oral contraceptives than with second …

Background and purpose of the workshop Concern about the venous thromboembolism
(VTE) risk of new hormonal contraceptive options shortly after their entry into the market has …

Research on the relationship between venous thromboembolism and the progestagen
content of combined oral contraceptives has pointed to an increase in risk associated with …

The relation of the risk of venous thromboembolism to the use of oral contraceptives was
assessed in a hospital-based study of 61 women suffering from a first episode of idiopathic …

For many years, it has been well documented that combined hormonal contraceptives
increase the risk of venous thromboembolism (VTE). The third-generation pill use …